Substantial Dose-response Relationship with Clinical Outcome for Lung Stereotactic Body Radiotherapy (SBRT) Delivered via Online Image Guidance

[1]  Peter Balter,et al.  Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer , 2012, Radiation oncology.

[2]  Geoffrey D. Hugo,et al.  Dosimetric impact of online correction via cone-beam CT-based image guidance for stereotactic lung radiotherapy. , 2010, International journal of radiation oncology, biology, physics.

[3]  Andrea Bezjak,et al.  Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.

[4]  Hong Ye,et al.  Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Lech Papiez,et al.  Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. , 2009, International journal of radiation oncology, biology, physics.

[6]  Tarek Mekhail,et al.  A Comparison of Two Stereotactic Body Radiation Fractionation Schedules for Medically Inoperable Stage I Non-small Cell Lung Cancer: The Cleveland Clinic Experience , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7]  Jan Nyman,et al.  Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Jan-Jakob Sonke,et al.  Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance. , 2009, International journal of radiation oncology, biology, physics.

[9]  Matthias Guckenberger,et al.  Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation. , 2009, International journal of radiation oncology, biology, physics.

[10]  J. Wong,et al.  Long-term Results of Computed Tomography Guided Hypofractionated Stereotactic Radiotherapy for Stage I Non-small Cell Lung Cancers , 2008 .

[11]  Y. Onodera,et al.  Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[12]  Hiroki Shirato,et al.  STEREOTACTIC RADIATION THERAPY WORKSHOP Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study , 2007 .

[13]  H. Geinitz,et al.  Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC) , 2006, Acta oncologica.

[14]  Masahiro Hiraoka,et al.  Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. , 2005, International journal of radiation oncology, biology, physics.

[15]  J. Wong,et al.  Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. , 2001, International journal of radiation oncology, biology, physics.

[16]  P. Blitzer,et al.  Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. , 1992, International journal of radiation oncology, biology, physics.